Press Release Blockchain & AI Eventon

PRESS RELEASE

2019-07-05 – Mumbai, India

Blockchain & AI Eventon
6th December, Novotel, Mumbai – India

 

 

STARTUP BATTLE – WHERE STARTUPS AND INVESTORS MEET

 

Blockchain & AI Eventon has announced a stellar show for 2019. The highly awaited show is expected to follow the grand success of the December summit in 2018, which brought Evan Singh Luthra, Ashley Turing, Giacomo Arcaro and Jaspreet Bindra to Mumbai and took the scene by storm even in times of a disturbing bear market. Blockchain & AI Eventon is announcing a Startup battle to take place at their upcoming summit in December 2019.

 

The inaugural edition of the startup Battle throws 15 of the most promising Crypto, Blockchain and AI projects into the ring to fight it out for an invaluable opportunity to pitch live on stage to a panel of savvy investors. The pitch is followed by a Q&A session from the official jury members, investors and the audience. Judging results will be based on the credibility of the company’s White Paper and invest-ability, with an importance placed on the business model and scalability.

 

Successful applicants can take advantage of several treats, such as VIP invitations to premium networking events in Mumbai and 10 complimentary tickets to the conference.

 

Winners will benefit from solid PR exposure across the Blockchain & AI Eventon’s media platforms, including video, email newsletters, website and magazines. The winning team will also receive a price of 20,000 dollars.

 

Applications are now open with just 12 spaces still available. Companies looking to put their names in the running should move quickly to secure their spot.

 

For more information about how you can get involved, please contact Nivas Naik at media@teflas.com

 

———————END-OF-PRESS-RELEASE—————-

 

For sharing in social media, please use these handles

 

Facebook: @Blockcahineventon

Instagram: @blockchain_ai_eventon

LinkedIn: @Blockchain & AI Eventon

Hashtags: #Blockchaineventon #AIeventon #Blockchainevent

 

Discuss

0 comment